Fluorescence activated enrichment of CD146+ cells during expansion of human bone-marrow derived mesenchymal stromal cells augments proliferation and GAG/DNA content in chondrogenic media

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Hagmann, Sebastien ^a,b   Frank, Sebastian ^a   Gotterbarm, Tobias ^a   Dreher, Thomas ^a   Eckstein, Volker ^a   Moradi, Babak ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD146; Chondrogenic differentiation; Mesenchymal stromal cells; MSC surface markers; Osteogenic differentiation; Sorting

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; CALCIUM; CD14 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; DNA; GLYCOSAMINOGLYCAN; THY 1 ANTIGEN; CULTURE MEDIUM; MCAM PROTEIN, HUMAN;

ADIPOGENESIS; ADULT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW DERIVED MESENCHYMAL STROMA CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL STRUCTURE; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; DONOR; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STROMA CELL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; AGED; BIOSYNTHESIS; BONE MARROW; CELL SEPARATION; FLOW CYTOMETRY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; STRUCTURAL GENE;

AGED; ANTIGENS, CD146; BONE MARROW; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHONDROGENESIS; CULTURE MEDIA; FEMALE; FLOW CYTOMETRY; GENES, GAG; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED;

EID: 84907974021     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-322     Document Type: Article

References (54)

1. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M, Exp Hematol 2008 36 1035 1046 10.1016/j.exphem.2008.03.004 18504067
2. Characterization of in vitro cultured bone marrow and adipose tissue-derived mesenchymal stem cells and their ability to express neurotrophic factors. Taghi GM, Ghasem Kashani Maryam H, Taghi L, Leili H, Leyla M, Cell Biol Int 2012 36 1239 1249 10.1042/CBI20110618 22994924
3. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B, Stem Cells 2007 25 750 760 17095706
4. High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. Yang XF, He X, He J, Zhang LH, Su XJ, Dong ZY, Xu YJ, Li Y, Li YL, J Biomed Sci 2011 18 59 10.1186/1423-0127-18-59 21854621
5. Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine. Barachini S, Trombi L, Danti S, D'Alessandro D, Battolla B, Legitimo A, Nesti C, Mucci I, D'Acunto M, Cascone MG, Lazzeri L, Mattii L, Consolini R, Petrini M, Stem Cells Dev 2009 18 293 305 10.1089/scd.2008.0017 18444788
6. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. Chong PP, Selvaratnam L, Abbas AA, Kamarul T, J Orthop Res 2012 30 634 642 10.1002/jor.21556 21922534
7. Proteomic validation of multifunctional molecules in mesenchymal stem cells derived from human bone marrow, umbilical cord blood and peripheral blood. Kim J, Shin JM, Jeon YJ, Chung HM, Chae JI, PLoS One 2012 7 32350 10.1371/journal.pone.0032350 22615730
8. Cartilage engineering from mesenchymal stem cells. Goepfert C, Slobodianski A, Schilling AF, Adamietz P, Portner R, Adv Biochem Eng Biotechnol 2010 123 163 200 20535603
9. Regulation of the differentiation of mesenchymal stem cells in vitro and osteogenesis in vivo by microenvironmental modification of titanium alloy surfaces. Hu Y, Cai K, Luo Z, Zhang Y, Li L, Lai M, Hou Y, Huang Y, Li J, Ding X, Zhang B, Sung KL, Biomaterials 2012 33 3515 3528 10.1016/j.biomaterials.2012.01.040 22333987
10. The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Lyons FG, Al-Munajjed AA, Kieran SM, Toner ME, Murphy CM, Duffy GP, O'Brien FJ, Biomaterials 2010 31 9232 9243 10.1016/j.biomaterials.2010.08.056 20863559
11. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM, Proc Natl Acad Sci U S A 2009 106 14022 14027 10.1073/pnas.0903201106 19666564
12. Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction. Wang J, Najjar A, Zhang S, Rabinovich B, Willerson JT, Gelovani JG, Yeh ET, Circ Cardiovasc Imaging 2012 5 94 101 10.1161/CIRCIMAGING.111.966424 22135400
13. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O, Lancet 2004 363 1439 1441 10.1016/S0140-6736(04)16104-7 15121408
14. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo. Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I, Stem Cells 2012 30 266 279 10.1002/stem.787 22102554
15. Recellularized nerve allografts with differentiated mesenchymal stem cells promote peripheral nerve regeneration. Wang Y, Zhao Z, Ren Z, Zhao B, Zhang L, Chen J, Xu W, Lu S, Zhao Q, Peng J, Neurosci Lett 2012 514 96 101 10.1016/j.neulet.2012.02.066 22405891
16. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A, Blood 2005 106 1755 1761 10.1182/blood-2005-04-1496 15905186
17. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R, Exp Hematol 2002 30 42 48 10.1016/S0301-472X(01)00769-X 11823036
18. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Batten P, Sarathchandra P, Antoniw JW, Tay SS, Lowdell MW, Taylor PM, Yacoub MH, Tissue Eng 2006 12 2263 2273 10.1089/ten.2006.12.2263 16968166
19. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM, Blood 2002 99 3838 3843 10.1182/blood.V99.10.3838 11986244
20. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Buhring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M, Ann N Y Acad Sci 2009 1176 124 134 10.1111/j.1749-6632.2009.04564.x 19796240
21. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Deschaseaux F, Gindraux F, Saadi R, Obert L, Chalmers D, Herve P, Br J Haematol 2003 122 506 517 10.1046/j.1365-2141.2003.04469.x 12877680
22. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Jones E, English A, Churchman SM, Kouroupis D, Boxall SA, Kinsey S, Giannoudis PG, Emery P, McGonagle D, Arthritis Rheum 2010 62 1944 1954 20222109
23. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Nasef A, Zhang YZ, Mazurier C, Bouchet S, Bensidhoum M, Francois S, Gorin NC, Lopez M, Thierry D, Fouillard L, Chapel A, Int J Lab Hematol 2009 31 9 19 10.1111/j.1751-553X.2007.00997.x 19143868
24. Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium. Okumura T, Wang SS, Takaishi S, Tu SP, Ng V, Ericksen RE, Rustgi AK, Wang TC, Lab Invest 2009 89 1410 1422 10.1038/labinvest.2009.88 19841619
25. A subset of IL-17(+) mesenchymal stem cells possesses anti-Candida albicans effect. Yang R, Liu Y, Kelk P, Qu C, Akiyama K, Chen C, Atsuta I, Chen W, Zhou Y, Shi S, Cell Res 2013 23 107 121 10.1038/cr.2012.179 23266891
26. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606
27. Novel markers for the prospective isolation of human MSC. Buhring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W, Ann N Y Acad Sci 2007 1106 262 271 10.1196/annals.1392.000 17395729
28. Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction. Iso Y, Yamaya S, Sato T, Poole CN, Isoyama K, Mimura M, Koba S, Kobayashi Y, Takeyama Y, Spees JL, Suzuki H, Stem Cells Transl Med 2012 1 462 468 10.5966/sctm.2011-0051 23197850
29. Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment. Rostovskaya M, Anastassiadis K, PLoS One 2012 7 51221 10.1371/journal.pone.0051221 23236457
30. Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Sivasubramaniyan K, Lehnen D, Ghazanfari R, Sobiesiak M, Harichandan A, Mortha E, Petkova N, Grimm S, Cerabona F, de Zwart P, Abele H, Aicher WK, Faul C, Kanz L, Bühring HJ, Ann N Y Acad Sci 2012 1266 94 106 10.1111/j.1749-6632.2012.06551.x 22901261
31. Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with NELL-1 protein. Askarinam A, James AW, Zara JN, Goyal R, Corselli M, Pan A, Liang P, Chang L, Rackohn T, Stoker D, Zhang X, Ting K, Péault B, Soo C, Tissue Eng Part A 2013 19 1386 1397 10.1089/ten.tea.2012.0367 23406369
32. An abundant perivascular source of stem cells for bone tissue engineering. James AW, Zara JN, Corselli M, Askarinam A, Zhou AM, Hourfar A, Nguyen A, Megerdichian S, Asatrian G, Pang S, Stoker D, Zhang X, Wu B, Ting K, Péault B, Soo C, Stem Cells Transl Med 2012 1 673 684 10.5966/sctm.2012-0053 23197874
33. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Covas DT, Panepucci RA, Fontes AM, Silva WA Jr, Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC, Zago MA, Exp Hematol 2008 36 642 654 10.1016/j.exphem.2007.12.015 18295964
34. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Dmitrieva RI, Minullina IR, Bilibina AA, Tarasova OV, Anisimov SV, Zaritskey AY, Cell Cycle 2012 11 377 383 10.4161/cc.11.2.18858 22189711
35. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Halfon S, Abramov N, Grinblat B, Ginis I, Stem Cells Dev 2011 20 53 66 10.1089/scd.2010.0040 20528146
36. Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells. Gharibi B, Hughes FJ, Stem Cells Transl Med 2012 1 771 782 10.5966/sctm.2010-0031 23197689
37. FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential. Hagmann S, Moradi B, Frank S, Dreher T, Kammerer PW, Richter W, Gotterbarm T, Cell Prolif 2013 46 396 407 10.1111/cpr.12046 23869761
38. A novel marker of human endometrial mesenchymal stem-like cells. Masuda H, Anwar SS, Buhring HJ, Rao JR, Gargett CE, Cell Transplant 2012 21 2201 2214 10.3727/096368911X637362 22469435
39. Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application. Rajaraman G, White J, Tan KS, Ulrich D, Rosamilia A, Werkmeister J, Gargett CE, Tissue Eng Part C Methods 2013 19 80 92 10.1089/ten.tec.2011.0718 22738377
40. A method to isolate, purify, and characterize human periodontal ligament stem cells. Mrozik K, Gronthos S, Shi S, Bartold PM, Methods Mol Biol 2010 666 269 284 10.1007/978-1-60761-820-1-17 20717790
41. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Baksh D, Yao R, Tuan RS, Stem Cells 2007 25 1384 1392 10.1634/stemcells.2006-0709 17332507
42. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P, Cell 2007 131 324 336 10.1016/j.cell.2007.08.025 17956733
43. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. Muschler GF, Boehm C, Easley K, J Bone Joint Surg Am 1997 79 1699 1709 9384430
44. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ, J Cell Biochem 1999 75 424 436 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8 10536366
45. Mesenchymal stem cell preparations-comparing apples and oranges. Wagner W, Ho AD, Stem Cell Rev 2007 3 239 248 10.1007/s12015-007-9001-1 18074246
46. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R, Stem Cell Res Ther 2014 5 53 10.1186/scrt442 24739658
47. Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC. Lv F, Lu M, Cheung KM, Leung VY, Zhou G, Curr Stem Cell Res Ther 2012 7 389 399 10.2174/157488812804484611 22934544
48. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC, Stem Cells 2010 28 788 798 10.1002/stem.312 20127798
49. Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. Dexheimer V, Frank S, Richter W, Stem Cells Dev 2012 21 2160 2169 10.1089/scd.2011.0670 22229819
50. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M, Stem Cells 2006 24 462 471 10.1634/stemcells.2004-0331 16109759
51. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R, Exp Hematol 2000 28 707 715 10.1016/S0301-472X(00)00160-0 10880757
52. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ, Br J Haematol 1999 107 275 281 10.1046/j.1365-2141.1999.01715.x 10583212
53. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG, J Bone Miner Res 1997 12 1335 1347 10.1359/jbmr.1997.12.9.1335 9286749
54. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Muller I, Schewe B, Skutella T, Fibbe WE, Kanz L, Bühring HJ, Haematologica 2009 94 173 184 10.3324/haematol.13740 19066333